ABVX — Abivax S.A. stock price, charts and financials

QT49Abivax S.A.

Abivax S.A. (NASDAQ: ABVX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
125.19
+0.41+0.33%
OverviewShort InterestFilings
ABVXQT49Abivax S.A.·NASDAQ
125.19+0.33%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 06, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jul 02, 20266-KForeign issuer report
Jul 02, 2026424B5Prospectus
Jul 01, 2026FWPFree writing prospectus
Jun 30, 2026FWPFree writing prospectus
Jun 30, 2026424B5Prospectus
Jun 30, 2026POSASRPOSASR
Jun 29, 20266-KForeign issuer report
Jun 02, 20266-KForeign issuer report
May 22, 20266-KForeign issuer report
May 20, 20266-KForeign issuer report
May 11, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 07, 20266-KForeign issuer report
May 07, 2026424B7424B7
Apr 20, 20266-KForeign issuer report
Mar 23, 202620-FAnnual report (foreign issuers)
Mar 23, 2026S-8Registration of employee benefit securities
Mar 23, 20266-KForeign issuer report
Feb 23, 20266-KForeign issuer report
Feb 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 14, 2026SC 13D/ABeneficial ownership statement (active, amended)
Dec 15, 20256-KForeign issuer report
Nov 14, 2025SC 13G/ABeneficial ownership statement (passive, amended)
Nov 14, 2025SC 13G/ABeneficial ownership statement (passive, amended)
Oct 30, 2025SC 13D/ABeneficial ownership statement (active, amended)
#1 / 25 of 74
Page
▼
/ 3